Ornella Barrandon
Senior Director Cellarity
Seminars
Wednesday 16th September 2026
Rewriting The Rules of Drug Discovery In Mash
10:00 am
- Our Discovery Platform leverages disease Atlases and deep learning to connect disease biology to chemical matter through transcriptomics
- Cellarity is leveraging our differentiated platform to identify novel druggable nodes to tackle advanced fibrotic disease in MASH
- Cellarity generated the largest human whole liver MASH Atlas to date. We established a highly relevant human in vitro model to capture the disease related signatures identified in our Atlas and that phenotypically captures multiple features of stellate activation including fibrogenesis & inflammation. Using our platform, we identified and validated essential processes causing disease-related cell dysfunction by testing predictions in vitro
